| Jamie L Tridico, | |
|
4301 Maccorkle Ave Se, Charleston, WV 25304-2503 | |
| (304) 720-9185 | |
| (304) 720-9186 |
| Full Name | Jamie L Tridico |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 31 Years |
| Location | 4301 Maccorkle Ave Se, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780882928 | NPI | - | NPPES |
| 3810009418 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1220 (West Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Physical Therapy, Pllc | 6103816806 | 6 |
News Archive
Many people who have been through cancer and its treatment have trouble with their recovery because of severe, debilitating fatigue that can last for months or even years. But even though a variety of treatments exist for cancer-related fatigue, few doctors are recommending them to patients, according to a recent Mayo Clinic study appearing in Supportive Care in Cancer.
Newborn babies exhibit a heightened response to pain when they are under stress, according to a study published in Current Biology. However, this is not detectable in babies' behaviour due to the stress causing a disconnect between their brain activity and their behavior.
Oxford BioMedica, a leading gene therapy company, announces that new data from the on-going Phase I/II trial of ProSavin for the treatment of Parkinson's disease were presented at the American Society of Gene & Cell Therapy 14th Annual Meeting held in Seattle, USA by Professor Stephane Palfi, Principal Investigator at the Henri Mondor Hospital in Paris, on Saturday 21 May 2011.
Cell Therapeutics, Inc. today announced that it had received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for Pixuvri™ (pixantrone dimaleate) for relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL").
Quantel Medical today announced that it has received approval from the U.S. Food and Drug Administration on July 25, 2017 for the innovative new Easyret fully integrated 577nm yellow photocoagulator, which is used to treat certain forms of macular edema and peripheral retinal pathologies.
› Verified 1 days ago
| Provider Name | Advanced Physical Therapy, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538236104 PECOS PAC ID: 6103816806 Enrollment ID: O20040514000666 |
News Archive
Many people who have been through cancer and its treatment have trouble with their recovery because of severe, debilitating fatigue that can last for months or even years. But even though a variety of treatments exist for cancer-related fatigue, few doctors are recommending them to patients, according to a recent Mayo Clinic study appearing in Supportive Care in Cancer.
Newborn babies exhibit a heightened response to pain when they are under stress, according to a study published in Current Biology. However, this is not detectable in babies' behaviour due to the stress causing a disconnect between their brain activity and their behavior.
Oxford BioMedica, a leading gene therapy company, announces that new data from the on-going Phase I/II trial of ProSavin for the treatment of Parkinson's disease were presented at the American Society of Gene & Cell Therapy 14th Annual Meeting held in Seattle, USA by Professor Stephane Palfi, Principal Investigator at the Henri Mondor Hospital in Paris, on Saturday 21 May 2011.
Cell Therapeutics, Inc. today announced that it had received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for Pixuvri™ (pixantrone dimaleate) for relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL").
Quantel Medical today announced that it has received approval from the U.S. Food and Drug Administration on July 25, 2017 for the innovative new Easyret fully integrated 577nm yellow photocoagulator, which is used to treat certain forms of macular edema and peripheral retinal pathologies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jamie L Tridico, 4301 Maccorkle Ave Se, Charleston, WV 25304-2503 Ph: (304) 720-9185 | Jamie L Tridico, 4301 Maccorkle Ave Se, Charleston, WV 25304-2503 Ph: (304) 720-9185 |
News Archive
Many people who have been through cancer and its treatment have trouble with their recovery because of severe, debilitating fatigue that can last for months or even years. But even though a variety of treatments exist for cancer-related fatigue, few doctors are recommending them to patients, according to a recent Mayo Clinic study appearing in Supportive Care in Cancer.
Newborn babies exhibit a heightened response to pain when they are under stress, according to a study published in Current Biology. However, this is not detectable in babies' behaviour due to the stress causing a disconnect between their brain activity and their behavior.
Oxford BioMedica, a leading gene therapy company, announces that new data from the on-going Phase I/II trial of ProSavin for the treatment of Parkinson's disease were presented at the American Society of Gene & Cell Therapy 14th Annual Meeting held in Seattle, USA by Professor Stephane Palfi, Principal Investigator at the Henri Mondor Hospital in Paris, on Saturday 21 May 2011.
Cell Therapeutics, Inc. today announced that it had received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for Pixuvri™ (pixantrone dimaleate) for relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL").
Quantel Medical today announced that it has received approval from the U.S. Food and Drug Administration on July 25, 2017 for the innovative new Easyret fully integrated 577nm yellow photocoagulator, which is used to treat certain forms of macular edema and peripheral retinal pathologies.
› Verified 1 days ago
Sarah Sturm, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 313 Maccorkle Ave Sw Ste 100, Charleston, WV 25303 Phone: 304-746-3704 Fax: 304-744-5891 | |
Scott Smolder, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Tracy Way Ste 100, Charleston, WV 25311 Phone: 304-720-0205 | |
Mrs. Mary Elizabeth Trethewey, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 699 S Park Rd, Charleston, WV 25304 Phone: 304-925-1532 | |
Adrienne J Harper, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 600 Tracy Way, Charleston, WV 25311 Phone: 304-388-4900 | |
Amy Ellison, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Association Dr, Charleston, WV 25311 Phone: 304-347-4372 | |
Nicole M Charbonniez, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Tracy Way, Charleston, WV 25311 Phone: 304-388-4900 | |
Improve Physical Therapy & Hand Center Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 4522 Maccorkle Ave Se Ste 1, Charleston, WV 25304 Phone: 304-552-8491 |